Jupiter Research Capital (Asia) Ltd’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,901
Closed -$1.14M – 906
2026
Q2
$1.14M Buy
+9,901
New +$851K 0.13% 205

Other funds holding KYMR

Jupiter Research Capital (Asia) Ltd's KYMR Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Kymera Therapeutics (KYMR) in Q3 2026, closing a stake of 9,901 shares — an estimated $1.14M sold.

Jupiter Research Capital (Asia) Ltd first reported a position in KYMR in Q2 2026 and held it in 1 quarter. The position peaked at $1.14M in Q2 2026. 277 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Kymera Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 9,901 Kymera Therapeutics shares in Q3 2026, an estimated $1.14M.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Kymera Therapeutics in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's Kymera Therapeutics position peaked at $1.14M in Q2 2026.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.